Long noncoding RNA MEG3 is downregulated in cervical cancer and affects cell proliferation and apoptosis by...

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Long noncoding RNAs (lncRNAs) are implicated in various human cancers.
• The specific role of lncRNAs in cervical cancer pathogenesis is largely uncharacterized.
• Maternally expressed gene 3 (MEG3) is a known cancer-related lncRNA with potential relevance.

Purpose of the Study:

• To investigate the biological function and molecular mechanism of MEG3 in cervical cancer.
• To determine if MEG3 expression is altered in cervical cancer tissues.
• To explore the relationship between MEG3 and clinical parameters and microRNA-21.

Main Methods:

• Quantitative real-time PCR (qRT-PCR) to assess MEG3 expression in 108 cervical cancer tissues and adjacent normal tissues.
• In vitro assays to evaluate the functional impact of MEG3.
• Analysis of correlations between MEG3 expression and clinical factors (FIGO stage, tumor size, metastasis) and HR-HPV infection.
• Investigation of the interaction between MEG3 and Homo sapiens microRNA-21 (miR-21).

Main Results:

• MEG3 expression was significantly downregulated in cervical cancer tissues compared to normal tissues.
• Lower MEG3 levels correlated with advanced FIGO stages, larger tumor size, lymphatic metastasis, and HR-HPV infection.
• MEG3 expression was inversely related to miR-21 expression.
• Overexpression of MEG3 suppressed cervical cancer cell proliferation and induced apoptosis, partly by reducing miR-21-5p levels.

Conclusions:

• MEG3 functions as a tumor suppressor in cervical cancer.
• MEG3 exerts its tumor-suppressive effects by regulating miR-21-5p.
• Targeting MEG3 may offer a novel therapeutic strategy for cervical cancer treatment.